NRC Health

The current price of NRC is $25.86 — it has increased by 1.49% since the previous close. Data as of Nov 6, 2026.

NRC is up 7.66% over the past week, up 28.08% over the past month and up 75.92% over the past year. The price is above its 200-day moving average of $19.24.

Of the 1 analyst covering NRC Health, 1 rates it a strong buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

NRC Health has a market capitalization of $572.01M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, NRC Health posted earnings of $0.21 per share against an estimate of $0.18, beating expectations by 16.67%. Upcoming reports are listed in the earnings calendar.

NRC Health reported revenue of $38.4M in its most recent quarter, which has increased by 10.96% compared with the same quarter a year earlier. Analysts had expected $35.8M.

Yes. NRC Health pays dividends quarterly. The latest payment of $0.16 per share has a payment date of Jan 8, 2027, which corresponds to a dividend yield of 2.47%.

Companies most comparable to NRC Health include HealthStream, Inc., Phreesia, Inc., SOPHiA GENETICS S.A., Claritev Corporation and Definitive Healthcare Corp.

In the latest trading session NRC moved between $24.98 and $25.97, a range of 3.83% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of NRC Health shows a buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for NRC Health is buy. Technical ratings are indicators, not investment advice.

Over the past 52 weeks NRC has traded between $11.74 and $27.41. The current price is 5.65% below its 52-week high.